TOB-STOP-COP (TOBacco STOP in COPd trial): study protocol—a randomized open-label, superiority, multicenter, two-arm intervention study of the effect of “high-intensity” vs. “low-intensity” smoking cessation intervention in active smokers with chronic obstructive pulmonary disease

[1]  J. Wedzicha,et al.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. , 2017, American journal of respiratory and critical care medicine.

[2]  J. Wedzicha,et al.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary , 2017, European Respiratory Journal.

[3]  E. A. V. van Eerd,et al.  Smoking cessation for people with chronic obstructive pulmonary disease. , 2016, The Cochrane database of systematic reviews.

[4]  A. Hofman,et al.  Chronic Obstructive Pulmonary Disease and the Risk of Stroke. The Rotterdam Study. , 2016, American journal of respiratory and critical care medicine.

[5]  J. Soriano,et al.  Global burden of COPD , 2016, Respirology.

[6]  L. Smeeth,et al.  Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis , 2015, BMJ Open.

[7]  P. Sivapalan,et al.  [Smoking water pipe is injurious to lungs]. , 2014, Ugeskrift for laeger.

[8]  Anthony J Alberg,et al.  Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. , 2013, Chest.

[9]  P. Tønnesen.  Smoking cessation and COPD , 2013, European Respiratory Review.

[10]  S. Rennard,et al.  Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients. , 2011, Respiratory medicine.

[11]  J. Wedzicha,et al.  Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.

[12]  Office on Smoking.  How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General , 2010 .

[13]  K. Larsson,et al.  High rate of smoking abstinence in COPD patients: Smoking cessation by hospitalization. , 2008, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[14]  L. Pbert.  Nurse-conducted smoking cessation in patients with COPD, using nicotine sublingual tablets and behavioral support. , 2006, Chest.

[15]  P. Tønnesen,et al.  Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support. , 2006, Chest.

[16]  M. Bartal.  COPD and tobacco smoke. , 2005, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[17]  Christian Gluud,et al.  Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial , 2005, BMJ : British Medical Journal.

[18]  J. Bourbeau,et al.  Outcomes and health‐related quality of life following hospitalization for an acute exacerbation of COPD , 2005, Respirology.

[19]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[20]  P. Sterk,et al.  Sputum induction , 2002, European Respiratory Journal.